Evolving from Past to Future: Facilitating SMART research
1Department of Anesthesia and Intensive Care, IRCCS San Raffaele Scientific Institute
2Faculty of Medicine, University of Melbourne, Melbourne, VIC, Australia
3Vita-Salute San Raffaele University, Milan, Italy
DOI: 10.22514/SV121.092016.1 Vol.12,Issue S1,October 2016 pp.14-18
Published: 10 October 2016
In clinical research, there has been an in-creasing need to titrate ethical, legal and insurance requirements to the type of study, so that higher-risk research receives necessary and appropriate detailed atten-tion, while low-risk studies can proceed more rapidly.
Spontaneous Medically Advantageous Research Trials (SMART) are non-profit studies that carry minimal or no risk to pa-tients. This type of investigation, however, is currently hampered by the fact that, in many hospitals and jurisdictions it has to undergo the same bureaucratic proce-dures and safety assessments as high-risk, for-profit studies. We strongly believe that such practice of scientific research assess-ment should be radically modified. We advocate a new, specific research category for SMART investigations that grants them a preferential route from conception to ethics assessment to execution. In addi-tion, we argue that such low risk studies assessing common, often not evidence-based applied treatments or investigations should in fact be a mandatory component of modern medicine. All clinicians, scien-tists, patients, patient associations, politi-cians, scientific associations and common citizens should be involved in this process, as they all play a crucial role in its evolu-tion and success.
We contend that modern medical research and entire health systems should transi-tion to a novel model of healthcare system where SMART execution is embedded into daily practice, in order to minimize anec-dotal practice and maximize evidence-based practice.
no profit study, medical re-search, ethical committee, progress
MARINA PIERI,RINALDO BELLOMO,ALBERTO ZANGRILLO,DARIO WINTERTON,GIOVANNI LANDONI. Evolving from Past to Future: Facilitating SMART research. Signa Vitae. 2016. 12(S1);14-18.
1. Institute of Medicine (US) Roundtable on Evidence-Based Medicine; Olsen LA, Aisner D, McGinnis JM, editors. The Learning Health-care System: Workshop Summary. Washington DC, (USA): National Academies Press; 2007.
2. Largent SJ, Miller FG. Can Research and Care Be Ethically Integrated? Hastings Cent Rep 2011;4:37-46.
3. WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects. [INTERNET] World Medical Association; 1964. [Last amended in October 2013; cited on October 3rd 2014] Available from: http://www.wma.net/en/30publications/10policies/b3/.
4. Faden RR, Kass NE, Goodman SN, Pronovost P, Tunis S, Beauchamp TL. An ethics framework for a learning healthcare system: a departure from traditional research ethics and clinical ethics. Hastings Cent Rep Spec No 2013; S16-S27.
5. Faden RR, Beauchamp TL, Kass NE. Informed consent, comparative effectiveness, and learning health care. N Engl J Med 2014;370:766-8.
6. Regulation (EU) No 536/2014. European Parliament; 2014. [INTERNET][Cited on October 14th 2014] Available from: http://ec.europa.eu/health/files/eudralex/vol-1/reg_2014_536/reg_2014_536_en.pdf.
7. Parsons H. What happened at Hawthorne? Science 1974;183:922–32.
8. Sommer R. The Hawthorne dogma. Psychol Bull 1968;70:592–5.
9. Wickstrom G, Bendix T. The “Hawthorne effect”—what did the original Hawthorne studies actually show? Scand J Work Environ Health 2000;26:363–7.
10. Gale E. The Hawthorne studies—a fable for our times? QJM 2004;97:439–49.
11. Chiesa M, Hobbs S. Making sense of social research: how useful is the Hawthorne effect? Eur J Soc Psychol 2008;38:67–74.
12. Landoni G, Pasin L, Monti G, Cabrini L, Beretta L, Zangrillo A. Towards zero perioperative mortality. Heart Lung Vessel 2013;5:133-6.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.
IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.
Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.
Scopus: CiteScore 0.5(2021) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.